Cingulate Inc.

Biotechnology • Healthcare • Kansas City, KS, United States • CINGW (NCM)

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

913 942 2300 1901 West 47th Place, Kansas City, KS 66205, United States Wikipedia

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Published on: 2025-12-28 21:49:46 - moha.gov.vn

moha.gov.vn • Dec 28

Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Yahoo Finance • Nov 13

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25 - TMX Newsfile

TMX Newsfile • Nov 18

Cingulate Stock Snaps 2-Day Losing Streak As Roth Hikes Target On ADHD Drug Review; Retail Bets On Buyout Potential - Stocktwits

Stocktwits • Oct 15

Cingulate Earnings Notes - Trefis

Trefis • Dec 15

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Cingulate Inc. had layoffs?

No layoff events have been recorded for Cingulate Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Cingulate Inc. have?

Cingulate Inc. has approximately 13 employees.

What industry is Cingulate Inc. in?

Cingulate Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Cingulate Inc. a publicly traded company?

Yes, Cingulate Inc. is publicly traded under the ticker symbol CINGW on the NCM.

Where is Cingulate Inc. headquartered?

Cingulate Inc. is headquartered in Kansas City, KS, United States at 1901 West 47th Place, Kansas City, KS 66205, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.